Groupe Jazz Pharmaceuticals plc

Action

Marché Fermé - Nasdaq 22:00:00 31/08/2026			Varia. 5j.	Varia. 1 janv.
250,68 ^USD	+2,51%		-1,49%	+47,46%

31/08	Jazz Pharmaceuticals annonce un bénéfice statistiquement significatif en matière de survie globale pour Ziihera associé à une chimiothérapie par rapport au trastuzumab plus chimiothérapie dans l'adénocarcinome gastro-œsophagien avancé HER2+ en première ligne	CI
31/08	L'essai de phase 3 de Jazz Pharmaceuticals démontre un bénéfice de survie pour le Ziihera dans le cancer gastro-œsophagien	MT

Société	Dirigeant
Jazz Securities DAC Jazz Securities DAC Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity	-
Jazz Investments II Ltd. Jazz Investments II Ltd. Finance/Rental/LeasingFinance Acts as a financing subsidiary/Special purpose entity	-
Jazz Financing Holdings Ltd. Jazz Financing Holdings Ltd. MiscellaneousMiscellaneous Functions as an investment holding company	-
Jazz Investments Europe Ltd.	-
Jazz Pharmaceuticals Ireland Ltd. Jazz Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the identification, development and commercialization of pharmaceutical products	Bruce Cozadd
Jazz Financing I DAC Jazz Financing I DAC Finance/Rental/LeasingFinance Issues Asset-backed/Mortgage-backed/Structured Finance securities	-
Jazz Pharmaceuticals Ireland Holdings Ltd.	-
Jazz Financing Lux SARL Jazz Financing Lux SARL Finance/Rental/LeasingFinance Provides financing services	-